Living Well With CLL | New York, NY

A Town Meeting for Patients, Families and Care Partners

 

Saturday, May 14, 2016
New York, NY 
 

An audience of CLL patients and their caregivers joined us at a recent town meeting along with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center to hear about emerging therapies in CLL, current treatment options and support resources.

We are also planning events in other cities. If you haven’t already, please sign up for email updates, so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.

 

Patient Folder

 

Checkpoint Inhibitors and CLL

Could checkpoint inhibitors be used to treat CLL? CLL expert, Dr. Nicole Lamanna, explains.

Published:

When Should Transplant Be Considered for CLL Patients?

Drs. Philip Thompson and Nicole Lamanna weigh in on a conversation about CLL and the appropriateness of transplant for treatment.

Published:

Why Is Venetoclax Approved for Only a Subset of Patients?

Drs. Nicole Lamanna and Philip Thompson discuss the recently approved venetoclax (Venclexta).

Published:

How Do CLL Inhibitor Treatments Work?

Dr. Nicole Lamanna explains CLL inhibitors: what is being inhibited, who is approved for these oral treatments, and how your doctor decides which is best for you.

Published:

What’s the Difference Between CLL and SLL?

CLL specialist Dr. Nicole Lamanna of Columbia University Medical Center explains the difference between the labels, CLL and SLL.

Published:

Why Is CLL So Varied?

Drs. Nicole Lamanna and Philip Thompson explain genetic variances and abnormalities in CLL cells.

Published:

Jennifer Abraham: Adjusting Your Sails After a CLL Diagnosis

Three-time cancer survivor and mother of two, Jennifer Abraham, explains why she feels her CLL diagnosis is a blessing in disguise.

Published:

What Does It Mean to Achieve MRD-Negative Status?

Andrew Schorr and Dr. Philip Thompson of MD Anderson Cancer Center discuss MRD negativity and its role in deciding ongoing treatment and whether it defines a cure for CLL.

Published:

Personalized Care and CLL

Andrew Schorr and Dr. Nicole Lamanna discuss the ever-changing landscape of CLL and the new role of patients and doctors in this era of personalized medicine.

Published:

Showing 9 of 11 programs


Guest Presenters

Associate Clinical Professor of Medicine

Columbia University Medical Center


Assistant Professor, Department of Leukemia, Division of Cancer Medicine


Adult Nurse Practitioner

Columbia University Medical Center


Oncology Social Worker

Columbia University Medical Center


Patient Advocate


Hosts

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and Patient Advocate


Online Host, Patient Power Co-Founder, Caregiver and Patient Advocate



This town meeting was provided by CLL Global Research Foundation, which received support from Acerta Pharma, Gilead Sciences, Inc., Pharmacyclics, Teva Pharmaceutical Industries Ltd and TG Therapeutics, Inc. and the Patient Empowerment Network, which received support from AbbVie Inc. and Genentech Inc. It was produced by Patient Power in partnership with The Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center.


Featured Blog
Introducing The Cancer Connection Facebook Page

By Andrew Schorr


Page last updated on October 20, 2016